Chest
-
Pulmonary Vascular Disease CasesSESSION TYPE: Case ReportsPRESENTED ON: Saturday, March 22, 2014 at 04:15 PM - 05:15 PMINTRODUCTION: 9th edition ACCP guidelines recommended against treating most patients with submassive pulmonary embolism (SPE) with systemic thrombolytics. We report a successful case of delayed use of recombinant tissue plasminogen activator (rtPA) for SPE causing refractory hypoxemia in a patient with a history of spontaneous subdural hemorrhage. ⋯ This case highlights that delayed use of rtPA should be considered in patients with SPE and refractory hypoxemia. History of spontaneous intracranial hemorrhage need not be an automatic absolute contraindication to rtPA use.Reference #1: Konstantinides S, et al. Heparin plus alteplase compared with heparin alone in patients with submassive pulmonary embolism. N Engl J Med 2002; 347(15):1143-1150Reference #2: Stein PD, et al. Risks for major bleeding from thrombolytic therapy in patients with acute pulmonary embolism. Ann Intern Med 1994;121:313-317DISCLOSURE: The following authors have nothing to disclose: Anita Rajagopal, Gabriel BossletNo Product/Research Disclosure Information.
-
Cardiovascular Case Report Posters IISESSION TYPE: Case Report PosterPRESENTED ON: Sunday, March 23, 2014 at 01:15 PM - 02:15 PMINTRODUCTION: Some important indications for use of hyperbaric oxygen therapy include treatment of diabetic ulcers, air embolism, carbon monoxide poisoning, and gas gangrene. It is usually well tolerated with very few side effects. We describe a case of acute pulmonary edema precipitated by hyperbaric oxygen treatment. ⋯ The following authors have nothing to disclose: Manveen Dassan, Vishesh Paul, Sameer Chadha, Nidhi Aggarwal, Yizhak Kupfer, Sidney TesslerNo Product/Research Disclosure Information.
-
Bronchiectasis PostersSESSION TYPE: Poster PresentationsPRESENTED ON: Saturday, March 22, 2014 at 01:15 PM - 02:15 PMPURPOSE: Low spirometry values are associated with increased risk for an exacerbation in patients with Chronic Obstructive Pulmonary Disease. There is paucity of data regarding patients with non-CF bronchiectasis. We endeavored to examine the possible relation between non-CF bronchiectasis exacerbations and pulmonary function tests. ⋯ The following authors have nothing to disclose: Evangelos Balis, Eugenios Metaxas, Joseph Papaparaskevas, Despina Chrysovergi, Nikos Spanakis, Athanasios Tsakris, Georgios TatsisNo Product/Research Disclosure Information.
-
Pediatric PostersSESSION TYPE: Poster PresentationsPRESENTED ON: Saturday, March 22, 2014 at 01:15 PM - 02:15 PMPURPOSE: Neonatal respiratory distress is any difficulty in breathing during the first 28 days of life. Clinical manifestations include a wide range depending on gestational age and its triggering causes. ⋯ The following authors have nothing to disclose: Manuela Cucerea, Monika Rusneac, Marta Simon, Carmen MovileanuNo Product/Research Disclosure Information.
-
Asthma Case Report PostersSESSION TYPE: Case Report PosterPRESENTED ON: Sunday, March 23, 2014 at 01:15 PM - 02:15 PMINTRODUCTION: Vocal cord dysfunction (VCD) is a syndrome characterized by glottic obstruction due to vocal cord adduction, with symptoms of wheezing and dyspnea (1). It is often mistakenly diagnosed as asthma, though the use of laryngoscopy can aid in the diagnosis, as was done in this case (2). ⋯ The following authors have nothing to disclose: Kaiser Lim, Sarah NarotzkyNo Product/Research Disclosure Information.